![Richard Pops](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard Pops
Patrimonio netto: 41 M $ in data 31/12/2025
Profilo
Richard F. Pops ha fondato la Sirtris Pharmaceuticals, Inc. Attualmente è presidente e amministratore delegato di Alkermes Plc e presidente e amministratore delegato di Alkermes, Inc. (una filiale di Alkermes Plc). È anche nel consiglio di Neurocrine Biosciences, Inc., Biotechnology Innovation Organization e Pharmaceutical Research & Manufacturers of America. Il signor Pops ha precedentemente ricoperto la posizione di consulente strategico presso Longwood Fund Management LLC, membro del consiglio di amministrazione presso la Harvard Medical School e direttore presso Sirtris Pharmaceuticals, Inc. Il signor Pops si è laureato alla Stanford University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 14/03/2025 | 1.290.390 ( 0,78% ) | 36 M $ | 31/12/2025 | |
| 22/05/2025 | 34.480 ( 0,03% ) | 5 M $ | 31/12/2025 |
Posizioni attive di Richard Pops
| Società | Posizione | Inizio |
|---|---|---|
| NEUROCRINE BIOSCIENCES, INC. | Direttore/Membro del Consiglio | 01/04/1998 |
| ALKERMES PLC | Amministratore Delegato | 01/02/1991 |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Direttore/Membro del Consiglio | - |
Alkermes, Inc.
 Alkermes, Inc. Manufactures and develops pharmaceutical products | Amministratore Delegato | 01/01/1991 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Richard Pops
| Società | Posizione | Fine |
|---|---|---|
| EPIZYME, INC. | Direttore/Membro del Consiglio | 31/10/2020 |
| ACCELERON PHARMA INC. | Direttore/Membro del Consiglio | 31/12/2019 |
The National Health Council
 The National Health Council Miscellaneous Commercial ServicesCommercial Services Provides united voice for people with chronic diseases and disabilities and their family caregivers | Direttore/Membro del Consiglio | 10/12/2019 |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/06/2012 |
| ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Richard Pops
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 17 |
|---|---|
Alkermes, Inc.
Alkermes, Inc. Manufactures and develops pharmaceutical products | |
Neurocrine Biosciences, Inc.
 Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders | Health Technology |
Expressive Constructs, Inc.
 Expressive Constructs, Inc. Pharmaceuticals: OtherHealth Technology Researches and develops antibody detection technologies | Health Technology |
Reliant Pharmaceuticals LLC
 Reliant Pharmaceuticals LLC Miscellaneous Commercial ServicesCommercial Services Develops amd markets pharmaceutical products | Commercial Services |
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company, which develops protein therapeutics for cancer and orphan diseases | Health Technology |
Sirtris Pharmaceuticals, Inc.
 Sirtris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures drugs and pharmaceuticals | Health Technology |
CombinatoRx, Inc.
 CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology Develops new medicines built from synergistic combinations of approved drugs | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
New England Healthcare Institute
 New England Healthcare Institute Miscellaneous Commercial ServicesCommercial Services Engages in identifying innovations that improve the quality and lower the costs of health care | Commercial Services |
Epizyme, Inc.
 Epizyme, Inc. BiotechnologyHealth Technology Develops therapeutics for the treatment of patients with genetically defined cancers | Health Technology |
The National Health Council
The National Health Council Miscellaneous Commercial ServicesCommercial Services Provides united voice for people with chronic diseases and disabilities and their family caregivers | Commercial Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Longwood Fund Management LLC
 Longwood Fund Management LLC Investment ManagersFinance Longwood Fund invests in companies located in the United States. The firm focuses on the healthcare sector. It participates in early stage capital transactions. | Finance |
Zalicus, Inc.
 Zalicus, Inc. Discovers and develops pharmaceutical products for patients suffering from pain and immuno-inflammatory diseases | |
Alkermes Plc
 Alkermes Plc Manufactures and commercializes pharmaceutical products to treat neurodegenerative disorders and cancer |
